FADS3 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

GO_0006636Biological processunsaturated fatty acid biosynthetic process
GO_0006629Biological processlipid metabolic process
GO_0006665Biological processsphingolipid metabolic process
GO_0016020Cellular componentmembrane
GO_0005789Cellular componentendoplasmic reticulum membrane
GO_0016717Molecular functionoxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water
GO_0005515Molecular functionprotein binding
GO_0003674Molecular functionmolecular_function

IV. Literature review

[source]
Gene nameFADS3
Protein nameFatty acid desaturase 3
Fatty acid desaturase 3 (FADS3) (EC 1.14.19.-) (Delta(13) fatty acid desaturase) (Delta(13) desaturase)
SynonymsCYB5RP
DescriptionFUNCTION: Mammals have different sphingoid bases that differ in their length and/or pattern of desaturation and hydroxyl groups. The predominant sphingoid base that comprises mammalian ceramides is sphing-4-enine (sphingosine or SPH) which has a trans (E) desaturation at carbon 4 . FADS3 is a desaturase that introduces a cis (Z) double bond between carbon 14 and carbon 15 of the sphingoid base (also known as long chain base, LCB), producing LCBs such as sphinga-4,14-dienine (SPD, d18:2(4E,14Z)) from SPH . Prefers SPH-containing ceramides (N-acylsphing-4-enines) as substrates . Capable of metabolizing also the SPH in its free form . SPD ceramides occur widely in mammalian tissues and cells . Due to their unusual structure containing a cis double bond, SPD ceramides may have an opposite, negative role in lipid microdomain formation relative to conventional ceramides . Could be involved in the detoxification of 1-deoxy sphingolipids, by desaturating the cytotoxic 1-deoxysphinganine (1-deoxySA, m18:0), produced under pathological conditions, to 1-deoxysphingenine (1-deoxysphingosine, 1-deoxySO, m18:1) (Probable). Although prefers SPH-containing ceramides (N-acylsphing-4-enines) as substrates, it also exhibits activity toward dihydrosphingosine-containing CERs (N-acylsphinganines) and produces 14Z-SPH-containing sphingolipids,which can be found in patients with DEGS1 mutations . Its desaturase mechanism involves an electron transfer facilitated by cytochrome b5 . FADS3 also acts as a methyl-end fatty acyl coenzyme A (CoA) desaturase that introduces a cis double bond between the preexisting double bond and the terminal methyl group of the fatty acyl chain (By similarity). Desaturates (11E)-octadecenoate (trans-vaccenoate, the predominant trans fatty acid in human milk) at carbon 13 to generate (11E,13Z)-octadecadienoate (also known as conjugated linoleic acid 11E,13Z-CLA) (By similarity). .

AccessionsENST00000525094.5
ENST00000531956.5
E9PKP8
ENST00000534223.5
Q9Y5Q0
ENST00000278829.7
H0YED5
E9PQC2
ENST00000527379.5
E9PPZ4
ENST00000527697.5
E9PS00
ENST00000525588.5
H0YCN1